US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

First Trust Energy Alphadex Fund

15.23

-0.2400-1.55%

Post-market: 15.230.00000.00%16:10 EDT

Volume:423.46K

Turnover:6.47M

Market Cap:273.38M

PE:- -

High:15.52

Open:15.45

Low:15.14

Close:15.47

Loading ...

Overview Company News Filings

Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia

Buffett-Backed Nu Holdings Stock Drops After Worse-Than-Expected Q1 Results: Details

Press Release: Nu Holdings Ltd. Reports First Quarter 2025 Financial Results

BD Reports Second Quarter Fiscal 2025 Financial Results

Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/FXN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FXN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXN\",,,,,undefined,":{"symbol":"FXN","market":"US","secType":"STK","nameCN":"First Trust Energy Alphadex Fund","latestPrice":15.23,"timestamp":1752696000000,"preClose":15.47,"halted":0,"volume":423460,"hourTrading":{"tag":"盘后","latestPrice":15.23,"preClose":15.23,"latestTime":"16:10 EDT","volume":6,"amount":91.38,"timestamp":1752696603748},"delay":0,"floatShares":17950002,"shares":17950002,"eps":0,"marketStatus":"Post-Mkt","change":-0.24,"latestTime":"07-16 19:12:12 EDT","open":15.45,"high":15.52,"low":15.14,"amount":6469200.3244,"amplitude":0.024564,"askPrice":16.73,"askSize":100,"bidPrice":13.78,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1752710400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":15.47,"sharesOutstanding":17950002,"nav":15.82,"aum":283969031.64,"dividendRate":0.029547,"bidAskSpread":0.000679,"postHourTrading":{"tag":"盘后","latestPrice":15.23,"preClose":15.23,"latestTime":"16:10 EDT","volume":6,"amount":91.38,"timestamp":1752696603748},"volumeRatio":0.707508,"impliedVol":0.0046,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXN\",,,,,undefined,":{"symbol":"FXN","floatShares":17950002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.707508,"shares":17950002,"dividePrice":0.45,"high":15.52,"amplitude":0.024564,"preClose":15.47,"low":15.14,"week52Low":12.5483,"pbRate":"--","week52High":18.94,"institutionHeld":0,"latestPrice":15.23,"eps":0,"divideRate":0.029547,"volume":423460,"delay":0,"ttmEps":0,"open":15.45,"prevYearClose":16.34,"prevWeekClose":16.12,"prevMonthClose":15.18,"prevQuarterClose":15.18,"fiveDayClose":15.89,"twentyDayClose":16.07,"sixtyDayClose":14.23},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FXN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549549950","title":"Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia","url":"https://stock-news.laohu8.com/highlight/detail?id=2549549950","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549549950?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:00","pubTimestamp":1751972400,"startTime":"0","endTime":"0","summary":"Nonclinical findings provide evidence of the mechanism of action of nomlabofusp and support the potential use of skin FXN concentrations as a novel surrogate endpoint for Larimar’s planned BLA submiss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/08/3111592/0/en/Larimar-Therapeutics-Publishes-Nonclinical-Data-Supporting-the-Therapeutic-Potential-of-Nomlabofusp-in-Patients-with-Friedreich-s-Ataxia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FA","BK4139","BK4539","LENZ","BK4130","BK4007","FXN","BK4535"],"gpt_icon":0},{"id":"2535957033","title":"Buffett-Backed Nu Holdings Stock Drops After Worse-Than-Expected Q1 Results: Details","url":"https://stock-news.laohu8.com/highlight/detail?id=2535957033","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535957033?lang=en_us&edition=fundamental","pubTime":"2025-05-14 05:40","pubTimestamp":1747172426,"startTime":"0","endTime":"0","summary":"Here&#39;s a look at Nu Holdings&#39; first-quarter earnings report.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45393936/buffett-backed-nu-holdings-stock-drops-after-worse-than-expected-q1-results-details","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1366333091.USD","BK4581","LU1280957306.USD","BK4176","IE00BK4W5M84.HKD","LU0048573561.USD","LU0210535034.USD","LU0130102774.USD","LU0214875030.USD","LU0742534661.SGD","LU0256859116.SGD","BK4588","LU0254981946.USD","LU0683600562.USD","LU0196696701.USD","IE00B1B80R65.USD","IE00B775SV38.USD","LU2168563687.JPY","IE00BK4W5L77.USD","LU0265267285.USD","LU0234570918.USD","LU0531970944.HKD","LU1363072403.SGD","BK4550","LU0531971322.HKD","NU","LU0154236417.USD","BK4534","LU0234572021.USD","LU1201861249.SGD","LU0396314238.USD","IE000M9KFDE8.USD","LU0640476718.USD","BK4585","IE0034235303.USD","FXN","LU1861217088.USD","LU0980610538.SGD","LU0170899867.USD","LU0050427557.USD","BK4533","LU0149725797.USD","LU0787776722.HKD","LU2125910500.SGD","LU2168564222.USD","LU0251143458.SGD","LU0086394185.USD","LU1914381329.SGD","LU2045819591.USD"],"gpt_icon":1},{"id":"2535403862","title":"Press Release: Nu Holdings Ltd. Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535403862","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535403862?lang=en_us&edition=fundamental","pubTime":"2025-05-14 05:15","pubTimestamp":1747170900,"startTime":"0","endTime":"0","summary":"Nu Holdings Ltd.  , one of the largest digital financial services platforms in the world, released its First Quarter 2025 financial results today. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards . The full earnings release has been made available on the Company's Investor Relations website at www.investors.nu, as well as the details of the Earnings Conference Call Nu will hold today at 6:00 pm Eastern time/7:00 pm Brasilia time.Below are the Q1'25 performance highlights of Nu Holdings Ltd.:. -- Customer growth: Nu added 4.3 million customers in Q1'25, driving a 19%. year-over-year  increase of 19.3 million, reaching a total of 118.6. million customers globally by March 31, 2025. Of that total, 104.6. million are in Brazil, 11 million in Mexico, and Colombia nearly reached. 3 million customers, maintaining its positive momentum following the. launch of the Nu Cuenta product. This expansion reinforces Nu's p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196696701.USD","IE00B1B80R65.USD","BK4206","BK4207","LU0214875030.USD","LU1481012133.USD","LU1861220207.SGD","LU2125910500.SGD","BK4559","LU1861217088.USD","LU0456842615.SGD","LU0048575426.USD","LU0196696453.USD","LU0254981946.USD","LU0251143458.SGD","LU0050427557.USD","FXN","LU0106259046.USD","LU0265267285.USD","LU0265266980.USD","LU0531970944.HKD","LU0449509016.USD","BK4590","NIM","IEP","LU0531971322.HKD","LU0396314238.USD","NU","LU0256859116.SGD","LU0210535034.USD","LU2360107671.USD","LU0261950470.USD","LU0086394185.USD","LU2045819591.USD"],"gpt_icon":0},{"id":"2532078226","title":"BD Reports Second Quarter Fiscal 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2532078226","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532078226?lang=en_us&edition=fundamental","pubTime":"2025-05-01 18:30","pubTimestamp":1746095400,"startTime":"0","endTime":"0","summary":"Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic. GAAP and adjusted diluted EPS of $1.07 and $3.35, respectively. Company updates full-year fiscal 2025 guidance and provides estimated tariff impact. FRANKLIN LAKES,N.J., May 1, 2025 /PRNewswire/ -- BD  , a leading global medical technology company, today announced results for its fiscal 2025 second quarter, which ended March31, 2025.\"Amid a difficult operating environment impacting near-term organic revenue growth, our Q2 results reflect the strength of our business model and ability to exceed our earnings expectations through quality gross margin improvement,\" said Tom Polen, chairman, CEO and president of BD. \"Our BD Excellence operating system is driving continued margin expansion and increasing investment in our commercial organization and innovation, and we believe we are well positioned to accelerate growth as markets recover. As we take decisive mitigation actions to navigate the current ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bd-reports-second-quarter-fiscal-103000884.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bd-reports-second-quarter-fiscal-103000884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4226","LU0511384066.AUD","ET","LU0985489474.SGD","BK4213","LU1150488135.SGD","LU0289739343.SGD","BK4504","LU0068578508.USD","BK4585","LU1854103824.USD","LU0433182093.SGD","BK4581","BK4144","BK4588","BK4082","BK4141","LU0266013472.USD","MMS","FXN","PI","SM","BK4590","BDX","LU0289961442.SGD","LU1150488218.USD","LU1059921491.USD","LU1489326972.SGD","BK4106","IDE","LU1854104046.USD","LU1878469433.USD","LU1571399168.USD","BK4132","LU1894683264.USD","LU1894683348.USD","BK4139","BK4561","LU0985320562.USD","APM","LU0878866978.SGD","UCC","IE00BFXG1179.USD","SURG"],"gpt_icon":0},{"id":"2521469997","title":"Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2521469997","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521469997?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval. FDA recommended measuring skin FXN concentrations to support evidence of effectiveness for accelerated approval pathway and acknowledged submitted data appear sufficient to support relationship between increased skin FXN concentrations and relevant tissues such as heart, dorsal root ganglia and skeletal muscle. Larimar is continuing discussions with FDA on the adequacy of the safety data set to support BLA submission. BLA seeking accelerated approval targeted for submission by year-end 2025. FDA and EMA feedback obtained on global Phase 3 study protocol; study planned to initiate in mid-2025. Dr. Ben-Maimon continued, “Our open label extension  study continues to advance, with some participants on daily treatment for up to one year. We continue to actively enroll study participants, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/larimar-therapeutics-provides-nomlabofusp-development-110000420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FXN","BK4535","LENZ","LRMR","FA","BK4139","BK4130","BK4539","BK4181","PK","BK4218"],"gpt_icon":0},{"id":"2505427330","title":"Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia","url":"https://stock-news.laohu8.com/highlight/detail?id=2505427330","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505427330?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:30","pubTimestamp":1737466200,"startTime":"0","endTime":"0","summary":"- Only dual route gene transfer therapy in development to treat Friedreich’s ataxia with FDA IND clearance and Fast Track designation -. CHARLESTOWN, Mass., Jan. 21, 2025  -- Solid Biosciences Inc. , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it has received Fast Track designation from the U.S. Food and Drug Administration  for SGT-212, the Company’s, AAV-based gene therapy candidate for the treatment of Friedreich’s ataxia . SGT-212 will deliver the full-length frataxin gene via dual routes of administration incorporating intradentate nucleus  and intravenous  infusions, designed to promote restoration of therapeutic levels of the frataxin protein to address neurologic, cardiac and systemic clinical manifestations of FA.Fast Track designation is granted to products that are developed to treat serious or life-threatening conditions and demonstrate the potential to address unmet medical needs. This designat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/solid-biosciences-receives-fda-fast-133000083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4157","FAST","BK4539","IE00BYQQ9H92.USD","BK4588","FXN","SLDB","FA","BK4130","BK4535","BK4104","BK4567","BK4585","IDN","IE00B5TLWC47.USD","IE00BFXG0V08.USD","BK4023","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FXN\",params:#limit:5,,,undefined,":[{"date":"2025-06-26","symbol":"FXN","amount":0.0958,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Energy AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"},{"date":"2025-03-27","symbol":"FXN","amount":0.1085,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-27","defaultRemindTime":1743082200000,"name":"First Trust Energy AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-27","currency":"USD","dateTimestamp":1743048000000,"payDate":"2025-03-31"},{"date":"2024-12-13","symbol":"FXN","amount":0.0923,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust Energy AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"date":"2024-09-26","symbol":"FXN","amount":0.1566,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-26","defaultRemindTime":1727357400000,"name":"First Trust Energy AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-30","payableDate":"2024-09-26","currency":"USD","dateTimestamp":1727323200000,"payDate":"2024-09-30"},{"date":"2024-06-27","symbol":"FXN","amount":0.0789,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-27","defaultRemindTime":1719495000000,"name":"First Trust Energy AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-27","currency":"USD","dateTimestamp":1719460800000,"payDate":"2024-06-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FXN\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-23","recordDate":"2015-09-25","paymentDate":"2015-09-30","value":0.0857,"currency":"USD"},{"executeDate":"2015-12-23","recordDate":"2015-12-28","paymentDate":"2015-12-31","value":0.0685,"currency":"USD"},{"executeDate":"2016-03-23","recordDate":"2016-03-28","paymentDate":"2016-03-31","value":0.0276,"currency":"USD"},{"executeDate":"2016-06-22","recordDate":"2016-06-24","paymentDate":"2016-06-30","value":0.0573,"currency":"USD"},{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-30","value":0.0472,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FXN\",market:\"US\",delay:false,,,undefined,":{}}}